Skin Care Drug Co. Gets OK For Ch. 11 Wind-Down Plan

By Rick Archer · May 2, 2024, 1:13 PM EDT

A Delaware bankruptcy judge on Thursday said she would approve the unopposed and unanimously approved Chapter 11 wind-down plans of the company previously known as Timber Pharmaceuticals Inc....

To view the full article, register now.

Bankruptcy Scorecard


A New Jersey-based business focused on producing treatments for rare skin diseases, Timber Pharmaceuticals filed for bankruptcy protection in November with $6.5 million in secured debt and about $1.5 million in trade debt, saying the company had run out of cash while its expected marquee product was still in Phase 3 clinical trials. On Feb. 15, the bankruptcy court approved the debtor's request to be renamed as Trex.

Case Number



J. Kate Stickles


U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

Between $1,000,000 and $10 million

View Full Scorecard

Case Information

Case Title

Trex Wind-down, Inc.

Case Number




Nature of Suit

Date Filed

November 17, 2023